Psilocybin-assisted therapy

Psilocybin-assisted therapy involves using psilocybin, a compound found in certain mushrooms, alongside psychological support to treat mental health conditions like depression.

Several studies have investigated the effects of psilocybin-assisted therapy on depression and found that it can significantly reduce symptoms for some people. Research indicates that this form of therapy may be particularly effective when combined with supportive psychotherapy sessions. Studies also suggest a dose-response relationship, meaning higher doses might lead to greater improvements in depressive symptoms. Additionally, there is evidence showing benefits for patients with cancer who are experiencing major depressive disorder.

This therapy connects strongly with depression and psychological support methods like talk therapy. The evidence base is growing but still relatively new, so more research is needed to fully understand its long-term effects and optimal use.

Sources

• Psilocybin-assisted therapy for depression: A systematic review and meta-analysis. (PMID:37844352)
• Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. (PMID:33146667)
• Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial. (PMID:36938991)
• Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies. (PMID:37557019)
• Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder. (PMID:38105655)
• Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis. (PMID:39627679)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._